FIELD: medicine, phthisiology. SUBSTANCE: method involves administration of bestim in the dose 0.1 mg by intramuscular route, every day, treatment course is 5 injections. Invention promotes to the enhanced effectiveness of treatment of patients with pulmonary tuberculosis and can be used for treatment of pulmonary tuberculosis. EFFECT: enhanced effectiveness of treatment. 3 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PULMONARY TUBERCULOSIS AT PREDOMINANTLY PRODUCTIVE TYPE OF TISSUE REACTION | 2000 |
|
RU2204409C2 |
METHOD FOR TREATING ACUTE MILIARY PULMONARY TUBERCULOSIS | 1999 |
|
RU2188034C2 |
RECOMBINANT INFLUENZA VIRUS STRAINS EXPRESSING MYCOBACTERIAL PROTECTIVE ESAT-6 ANTIGEN AND USES THEREOF IN TUBERCULOSIS TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2318872C2 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
METHOD FOR TREATMENT OF DESTRUCTIVE AND PROGRESSING LUNG TUBERCULOSIS FORMS CAUSED BY DRUG-RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS | 2000 |
|
RU2215538C2 |
METHOD OF TREATING DESTRUCTIVE PULMONARY TUBERCULOSIS | 2010 |
|
RU2450820C2 |
METHOD OF TREATING PULMONARY TUBERCULOSIS IN HIV-INFECTION PATIENTS | 2008 |
|
RU2383342C1 |
METHOD OF TREATING PULMONARY TUBERCULOSIS FEATURING PREDOMINANTLY EXUDATIVE TYPE OF INFLAMMATION | 1990 |
|
RU2008902C1 |
METHOD FOR INCREASING ANTIGEN IMMUNOGENECITY OF B. pseudomallei ANTIGENS IN EXPERIMENTAL MELIOIDOSIS | 2012 |
|
RU2483752C1 |
METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
Authors
Dates
2004-06-10—Published
2001-06-08—Filed